FACTORS INFLUENCING ANTIRETROVIRAL TREATMENT FAILURE AMONG ADULT HIV PATIENTS ON TREATMENT AT BOMU HOSPITAL –MOMBASA COUNTY
Keywords:
Co-morbidities, ARV treatment, socioeconomic, CD4 counts and viral loadsAbstract
follow up Bomu Hospital, Mombasa County.
Materials and Methods: The study was a cross sectional at initial patient recruitment and retrospective for patient level data. 299 study participants were selected from a total of 18 425 active on ART. Convenient sampling technique was used to select the adult population for study and thereafter it was categorized into two groups. Semi-structured interview schedules were used to obtain demographic information and patients’ views on various dimensions of ART services at the hospital.
Results: Using Chi square test of independence (Fisher exact test) it was found that there was significant association at 5% level of significance between viral suppression and some of the social demographic factors namely marital status and age groups. Using multiple logistic regression model to determine which social demographic and social economic factors affect viral suppression, it was found that age groups and marital status are statistical significant at 10% and 5% respectively. The results showed that there was no significant relationship between period of treatment, co infections and viral suppression. There was positive significant relationship between the viral suppression and current CD4 count. The viral suppression was higher among those with high CD4 count.
Unique contribution to theory, practice and policy: Antiretroviral treatment success requires a multidimensional approach to achieve a complete viral suppression. These multidisciplinary team approaches that include doctors, nurses, pharmacists, counselors and family members must be available to coordinate some of the adherence-related activities. This also increases the likelihood that patients will find someone on the care team to whom they can comfortably relate and from whom they can get needed information about their medications
Downloads
References
Bansi L, Sabin C, Delpech V. Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Medicine (2010) 11:432 – 438
Bendavid E, Bhattacharya J: The President’s emergency plan for AIDS relief in Africa: an evaluation of outcomes. Ann intern Med 2009, 150(10): 688-695.
Campsmith, M. L., Nakashima, A. K., & Davidson, A. J. 2003. Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project. BiomedCentral, 1:12.
Delate, T., and Coons, S. J. 2001. The Use of 2 Health-Related Quality-of-Life Measures in a Sample of Persons Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases; 32: 47-52.
Finzi D, Blank son J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, and Siliciano RF: Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999, 5(5):512517.
Hirsch MS, Conway B, D’Aquila RT. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. JAMA. 1998; 279: 1984-1991.
Jahn A, Floyd S, Crampin Ac. Population– level effect on HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008, 371(9624):1603-1611.
Katrina F. Ortblad; Rafael Lozano; Christopher J.L. Murray. AIDS. 2013;27(13):2003-2017. © 2013
Mills, E. J., Bakanda, C., Birungi, J., Chan, K., et al. 2011. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med, 155(4), 209-216.
Mills, E. J., Bakanda, C., Birungi, J., Chan, K., et al. 2011. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med, 155(4), 209-216.
Nakagawa, F., Lodwick, R. K., Smith, C. J., et al., 2012. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012 Jan 28;26(3):335-43.
Palella FJ, Delaney KM, Moorman AC. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Medical Journal. (1998); 338 (13): 853–860
Paredes R, Mocroft A, Kirk O. Predictors of virological success and ensuing failure in HIV-positive patients starting Highly Active Antiretroviral Therapy in Europe. Arch Intern Med. (2000) 160:1123-1132
WHO, UNAIDS, UNICEF: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva 2009.
WHO: Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach, 2010 revision. Accessed 18 October 2012
WHO: Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents, November 2009. Accessed 18 October 2012.
Yazdan Y. Multidrug resistance: a clinical approach. Current Opinion HIV in AIDS (2009); 4: 499-506
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
